Logo image of IMVT

IMMUNOVANT INC (IMVT) Stock Analyst Ratings

NASDAQ:IMVT - Nasdaq - US45258J1025 - Common Stock - Currency: USD

21.11  +0.2 (+0.96%)

Buy % Consensus

88

ChartMill assigns a Buy % Consensus number of 88% to IMVT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 51.65. This target is 144.67% above the current price.
IMVT was analyzed by 20 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about IMVT.
In the previous month the buy percentage consensus was at a similar level.
IMVT was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
IMVT Historical Analyst RatingsIMVT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -59 -53 -47 -41 -35 -29 -23 -17 -11 -5 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 21.1141.4152.0251.6560.90 - 96.16% 146.42% 144.67% 188.49%
IMVT Current Analyst RatingIMVT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-01-15 B of A Securities Maintains Buy -> Buy
2025-01-03 Wolfe Research Downgrade Outperform -> Peer Perform
2024-12-19 Wells Fargo Maintains Overweight -> Overweight
2024-11-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-10 Raymond James Reiterate Outperform
2024-10-09 Oppenheimer Maintains Outperform -> Outperform
2024-09-30 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-09 Cantor Fitzgerald Reiterate Overweight
2024-08-13 UBS Maintains Buy -> Buy
2024-08-08 JP Morgan Maintains Overweight -> Overweight
2024-08-07 Cantor Fitzgerald Reiterate Overweight
2024-06-20 Cantor Fitzgerald Reiterate Overweight
2024-06-18 Cantor Fitzgerald Reiterate Overweight
2024-06-03 Oppenheimer Maintains Outperform -> Outperform
2024-05-30 Cantor Fitzgerald Reiterate Overweight
2024-05-30 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-28 Oppenheimer Initiate Outperform
2024-03-25 Truist Securities Reiterate Buy -> Buy
2024-03-13 Goldman Sachs Initiate Buy
2024-02-20 JP Morgan Initiate Overweight
2024-02-15 Wolfe Research Initiate Outperform
2023-12-21 B of A Securities Maintains Buy -> Buy
2023-12-21 HC Wainwright & Co. Maintains Buy -> Buy
2023-12-12 Deutsche Bank Initiate Buy
2023-12-01 UBS Maintains Buy -> Buy
2023-11-15 Truist Securities Maintains Buy -> Buy
2023-10-24 Piper Sandler Maintains Overweight -> Overweight
2023-10-24 HC Wainwright & Co. Maintains Buy -> Buy
2023-10-16 Cantor Fitzgerald Maintains Overweight -> Overweight